Bahl Lalit Rai
recently stated that they own a 8.4% stake in Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, April 13th. The investor owns 4,000,000 shares of the stock worth $720,000. The reporting parties listed on the disclosure included Lalit Bahl and Kavita K Kinra. The filing is available through the SEC website at this link.
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) traded up 0.000000% during midday trading on Thursday, hitting $0.182355. The firm’s market cap is $9.46 million. The company has a 50 day moving average of $0.19 and a 200-day moving average of $0.16. Lixte Biotechnology Holdings Inc has a one year low of $0.09 and a one year high of $0.42.
COPYRIGHT VIOLATION NOTICE: “8.4% Stake of Lixte Biotechnology Holdings Inc (LIXT) Owned by Bahl Lalit Rai” was first posted by sleekmoney and is owned by of sleekmoney. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://sleekmoney.com/8-4-stake-of-lixte-biotechnology-holdings-inc-lixt-owned-by-bahl-lalit-rai/1739207.html.
Lixte Biotechnology Holdings Company Profile
Lixte Biotechnology Holdings, Inc, including its subsidiary, Lixte Biotechnology, Inc, is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs compounds to attack those targets. The Company’s primary focus is developing new treatments for human cancers.
Want to see what other hedge funds are holding LIXT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lixte Biotechnology Holdings Inc (NASDAQ:LIXT).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/8-4-stake-of-lixte-biotechnology-holdings-inc-lixt-owned-by-bahl-lalit-rai/1739207.html
Receive News & Ratings for Lixte Biotechnology Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lixte Biotechnology Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.